The STEPS approach to apply integrated medicines management:
STEP I – clinical evaluation
STEP II – risk assessment
STEP III – budgetary impact analysis
STEP IV – final procurement selection
The new procurement model also allows for a radical redesign of the medicine tariff based upon safety, efficacy and economy. Flexibility is built into the process as it does not demand 100% compliance with the product selections, but rather, only requires a reasonable percentage compliance (70 – 80% depending on the group).
Information services / Support
- Reference procurement contracts
- Linkage of procurement information to product data and selection
- Guidance examples resulting from the process
- Consultancy: how contracting has been carried out and how procurement contracts can be re-applied in any specific setting.
